Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21709 | 351 | 46.8 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FN14 | Author keyword | 134 | 83% | 21% | 75 |
2 | TWEAK | Author keyword | 131 | 69% | 32% | 111 |
3 | STWEAK | Author keyword | 49 | 94% | 5% | 17 |
4 | TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS | Author keyword | 15 | 73% | 3% | 11 |
5 | FIBROBLAST GROWTH FACTOR INDUCIBLE 14 | Author keyword | 12 | 86% | 2% | 6 |
6 | FIBROBLAST GROWTH FACTOR INDUCIBLE 14 FN14 | Author keyword | 8 | 100% | 1% | 5 |
7 | TWEAKR | Author keyword | 8 | 100% | 1% | 5 |
8 | TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS TWEAK | Author keyword | 6 | 100% | 1% | 4 |
9 | PULM PHARMACOTHER Y | Address | 4 | 75% | 1% | 3 |
10 | NEPHROL VASC PATHOL | Address | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WEAK INDUCER | 247 | 85% | 38% | 132 |
2 | APOPTOSIS TWEAK | 82 | 92% | 9% | 33 |
3 | MULTIFUNCTIONAL CYTOKINE | 75 | 91% | 9% | 31 |
4 | FIBROBLAST GROWTH FACTOR INDUCIBLE 14 | 73 | 96% | 7% | 23 |
5 | FN14 | 64 | 82% | 11% | 37 |
6 | RECEPTOR FN14 | 52 | 100% | 5% | 18 |
7 | TWEAK | 49 | 61% | 15% | 51 |
8 | TWEAK FN14 INTERACTION | 45 | 94% | 5% | 16 |
9 | STWEAK | 18 | 89% | 2% | 8 |
10 | SOLUBLE TWEAK | 11 | 78% | 2% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses | 2011 | 52 | 86 | 78% |
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting | 2008 | 216 | 126 | 59% |
TWEAK and the progression of renal disease: clinical translation | 2014 | 3 | 69 | 80% |
The TWEAK-Fn14 system as a potential drug target | 2013 | 10 | 123 | 82% |
TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK/Fn14 pathway in health and disease | 2007 | 99 | 90 | 64% |
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease | 2014 | 2 | 47 | 60% |
Role of theTWEAK-Fn14-cIAP1-NF-kappa B signaling axis in the regulation of myogenesis anc muscle homeostasis | 2014 | 5 | 135 | 29% |
The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases | 2012 | 15 | 107 | 63% |
TWEAK/Fn14 axis-targeted therapeutics: moving basic science discoveries to the clinic | 2013 | 7 | 128 | 69% |
TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities | 2014 | 1 | 57 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PULM PHARMACOTHER Y | 4 | 75% | 0.9% | 3 |
2 | NEPHROL VASC PATHOL | 2 | 67% | 0.6% | 2 |
3 | SKELETAL MUSCLE PHYSIOL NEUROBIOL | 2 | 67% | 0.6% | 2 |
4 | EXPLORATORY SCI | 2 | 25% | 1.7% | 6 |
5 | BIOMED NETWORK DIABET ASSOCIATED METAB | 1 | 100% | 0.6% | 2 |
6 | UNIT DETECT TREATMENT ATHEROTHROMBOT DIS | 1 | 100% | 0.6% | 2 |
7 | VASC EACH | 1 | 100% | 0.6% | 2 |
8 | CARDIOL ANGIOL PULMOL | 1 | 27% | 1.1% | 4 |
9 | FDN RENAL INIGO ALVAREZ TOLEDO | 1 | 24% | 1.1% | 4 |
10 | IMMUNOL DISCOVERY | 1 | 18% | 1.4% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141369 | DCR3//DECOY RECEPTOR 3//TL1A |
2 | 0.0000088734 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
3 | 0.0000076030 | HAPTOGLOBIN//HAPTOGLOBIN POLYMORPHISM//HAPTOGLOBIN PHENOTYPES |
4 | 0.0000066159 | TAK1//TRAF4//TRAF5 |
5 | 0.0000065139 | BAFF//APRIL//BLYS |
6 | 0.0000062755 | MURF1//ATROGIN 1//ATROGIN 1 MAFBX |
7 | 0.0000041405 | INFLAMMATORY DIS//NEPHROTOXIC NEPHRITIS//IMMUNOL IMM5 |
8 | 0.0000038711 | SECT ZOOL CYTOL//KEYMOLNET//RELA ACETYLATION |
9 | 0.0000036338 | VASC PHYSIOPATHOL//MEDIA LAYER//CORONARY ATHEROSCLEROTIC HEART DISEASE |
10 | 0.0000035473 | PENTRAXIN 3//PTX3//PENTRAXIN |